Semaglutide, originally developed to regulate blood sugar in individuals with type 2 diabetes, has gained traction as an effective weight-loss treatment. Marketed under the brand name Wegovy, the drug was approved by the U.S. Food and Drug Administration (FDA) in 2021 for chronic weight management in adults with obesity or overweight.
With increasing demand for semaglutide, the United States is facing a shortage, leading some pharmacies to offer unregulated, compounded versions of the drug. These alternatives lack FDA approval, raising concerns about safety, purity, and effectiveness. Patients are advised to use only FDA-approved versions such as Ozempic, Wegovy, and Rybelsus and consult healthcare professionals regarding their medications.
Eligibility for Semaglutide Use
The FDA has approved Wegovy for adults diagnosed with obesity (BMI of 30 or higher) and those classified as overweight (BMI between 27 and 29.9) with at least one weight-related health condition, such as:
- High blood pressure
- Type 2 diabetes
- High cholesterol
A medical professional can assess an individual’s suitability for semaglutide treatment.
Mechanism of Action
Semaglutide facilitates weight loss by influencing the brain’s hypothalamus, which regulates appetite. It promotes weight reduction by:
- Enhancing feelings of fullness
- Suppressing hunger
- Decreasing cravings for high-fat foods
While semaglutide aids weight loss, its efficacy is optimized when combined with a low-calorie diet and increased physical activity. Healthcare providers can offer personalized dietary and exercise recommendations to enhance outcomes.
Efficacy of Semaglutide for Weight Loss
A 2024 study involving 17,604 participants with cardiovascular disease, obesity, or overweight demonstrated significant and sustained weight loss over four years. The study found semaglutide effective across diverse demographics, including varying body sizes, genders, and ethnic backgrounds.
A 2022 review further indicated that a weekly 2.4 mg dose of semaglutide, administered over 68 weeks alongside a reduced-calorie diet and increased exercise, resulted in an average body weight reduction of 9.64%.
Potential Side Effects
Like all medications, semaglutide may cause side effects. Common adverse effects include:
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Constipation
- Heartburn
- Burping
In rare cases, severe side effects may occur, necessitating immediate medical attention:
- Persistent abdominal pain, with or without vomiting
- Swelling of the face, eyes, mouth, tongue, or throat
- Difficulty breathing or swallowing
- Swelling in the legs, ankles, or feet
- Vision disturbances
- Fainting, dizziness, or confusion
- Jaundice (yellowing of the skin or eyes)
- Clay-colored stools
- Rapid heartbeat
- Slurred speech or blurred vision
Associated Risks and Contraindications
Although generally considered safe, semaglutide should only be used under a physician’s supervision. The medication carries an increased risk of medullary thyroid cancer and biliary disease. Patients should avoid semaglutide if they:
- Have a history of thyroid cancer
- Suffer from kidney or pancreatic issues
- Are pregnant or planning pregnancy
- Are breastfeeding or chestfeeding
Administration Guidelines
Semaglutide is administered via subcutaneous injection in areas with adequate body fat, such as the abdomen, upper arm, or thigh. To ensure proper dosing, patients should adhere to their prescribed injection protocol, following these steps:
- Select a clean, dry injection site.
- Remove the pen cap and press the needle cover firmly against the skin.
- Maintain pressure until the pen’s yellow indicator bar stops moving and two clicks are heard.
- Continue pressing to prevent leakage and ensure full dosage delivery.
- Once completed, withdraw the pen slowly.
Minor bleeding may occur at the injection site, which can be managed with a clean cotton ball.
Frequently Asked Questions
How much weight can I lose in a month with semaglutide?
Weight loss results vary based on factors such as individual metabolism, dietary habits, and exercise routines.
Is semaglutide safe for weight loss?
Semaglutide is considered safe for weight management when prescribed and monitored by a healthcare provider, ensuring suitability and minimizing potential risks.
Conclusion
Semaglutide has emerged as a promising treatment for long-term weight management, helping individuals achieve and maintain weight loss by increasing satiety and reducing hunger. However, its effectiveness is maximized when combined with a healthy lifestyle, including proper nutrition and physical activity. Patients considering semaglutide should consult a medical professional to determine whether it is an appropriate option for their needs.
Related Topics:
Do Weight Loss Injections Improve or Endanger Your Health?
Weight-Loss Drug Ozempic Shows Promise in Reducing Alcohol Cravings
Tirzepatide vs. Semaglutide Side Effects — How Do They Compare?
